Advertisement
Advertisement
U.S. Markets close in 5 hrs 20 mins
Advertisement
Advertisement
Advertisement
Advertisement

Alseres Pharmaceuticals, Inc. (ALSE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 05:09PM EDT. Market open.
Advertisement
Advertisement

Insider Roster

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date

BOBE FRANK
Officer

Stock Award(Grant)

Jan 01, 2008

3,363

GIPSON ROBERT L
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security

Dec 21, 2011

17,707,000

GIPSON THOMAS LIVINGSTON
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security

Dec 21, 2011

5,393,940

HILLSON S DAVID
Chief Executive Officer

Sale

Dec 30, 2002

102,000

PALMER E CHRISTOPHER
Former

Conversion of Exercise of derivative security

Jul 05, 2004

54,100

PECK STEPHEN M
Director

Purchase

Jul 30, 2002

20,000

PYKETT MARK JEROME
President

Stock Award(Grant)

Jan 01, 2008

6,777

RICE KENNETH L JR
Chief Financial Officer

Stock Award(Grant)

Jan 01, 2008

4,485

ROSENTHAL ROBERT
Chief Operating Officer

Purchase

Aug 28, 2002

5,000

SAVAS PETER G
Chief Executive Officer

Stock Award(Grant)

Jan 01, 2008

11,212

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Advertisement
Advertisement